These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 3910405)

  • 1. [Mechanisms, kinetics and specificity of the leukocyte adherence inhibition test in breast cancer].
    Kharkevich DD; Polevaia EB; Derevnina NA; Sablikova IuA; Savinov AIu
    Eksp Onkol; 1985; 7(6):69-73. PubMed ID: 3910405
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Micromodification of the leukocyte adherence inhibition test for cancer patients].
    Kharkevich DD; Tabagari DZ; Savinov AIu
    Vopr Onkol; 1985; 31(7):17-21. PubMed ID: 3895734
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Specificity of tumor antigen recognition by T-lymphocytes in the leukocyte adherence inhibition (LAI) assay in patients with breast cancer.
    Tsang PH; Holland JF; Bekesi JG
    J Clin Lab Immunol; 1982 Dec; 9(3):151-7. PubMed ID: 6762442
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antigenic specificity and cellular mechanisms in leukocyte adherence inhibition analysis of immunity to simple proteins and hapten-protein conjugates.
    Powell A; Sloss AM; Smith RN; Murrell H
    Cancer Res; 1979 Feb; 39(2 Pt 2):570-5. PubMed ID: 83911
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Requirement for autologous cancer extracts and lipoxygenation of arachidonic acid for human T-cell responses in leukocyte adherence inhibition and transmembrane potential change assays.
    Shenouda G; Thomson DM; MacFarlane JK
    Cancer Res; 1984 Mar; 44(3):1238-45. PubMed ID: 6420056
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The cellular mechanism of leukocyte adherence inhibition.
    Koppi TA; Maluish AE; Halliday WJ
    J Immunol; 1979 Nov; 123(5):2255-60. PubMed ID: 314958
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Immunodiagnostic studies in ovarian cancer using the leukocyte adherence inhibition test (LAI test). 1. Detection of cellular sensitization of peripheral blood lymphocytes using the LAI test].
    Ludwig HJ; Storch H
    Zentralbl Gynakol; 1986; 108(10):593-606. PubMed ID: 3526755
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blocking of the response by human T-lymphocytes to extracts of autologous cancer by monoclonal antibody to Class-I major histocompatibility complex gene products in the leukocyte adherence inhibition assay.
    Shenouda G; Thomson DM
    Cancer Res; 1984 Jul; 44(7):2762-8. PubMed ID: 6609766
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Humoral antitumor immune responses in patients with breast cancer measured with the leukocyte adherence inhibition technique.
    Kotlar HK; Sanner T
    J Natl Cancer Inst; 1981 Feb; 66(2):265-71. PubMed ID: 7005505
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Specific immunodiagnosis of hepatoma by tube leukocyte adherence inhibition assay and a modified method of repeated tube leukocyte adherence inhibition assay.
    Morizane T; Kumagai N; Tsuchimoto K; Watanabe T; Tsuchiya M
    Cancer Res; 1980 Aug; 40(8 Pt 1):2928-34. PubMed ID: 6248217
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Inhibition of the adherence of leukocytes labelled with Cr-51 in colorectal cancer].
    Mounielou PM; Clemente F; Estival A; Ribet A
    Gastroenterol Clin Biol; 1984 Oct; 8(10):736-41. PubMed ID: 6396147
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of the mechanism of the leukocyte adherence inhibition test.
    Tong AW; Burger DR; Finke P; Barney C; Vandenbark AA; Vetto RM
    Cancer Res; 1979 Feb; 39(2 Pt 2):597-603. PubMed ID: 367586
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Changes in sensitivity of lymphocyte cholinergic receptors in patients with breast cancer].
    Kharkevich DD; Polevaia EB
    Eksp Onkol; 1988; 10(5):38-40. PubMed ID: 2905257
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Leukocyte adherence inhibition responses obtained with various tumor extracts in breast cancer patients.
    Kovarík J; Lauerová L; Feit J; Ninger E; Munzarová M; Zemanová D; Hlávková J
    Cancer Detect Prev; 1983; 6(1-2):215-9. PubMed ID: 6349799
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Study of the participation of the alpha-chain of the LFA-1 antigen in the phenomenon of lymphocyte adherence inhibition using ICO-11 monoclonal antibodies in vitro].
    Kharkevich DD; Baryshnikov AIu; Savel'eva EV; Polevaia EB; Kadagidze ZG
    Biull Eksp Biol Med; 1987 Dec; 104(12):711-3. PubMed ID: 3318954
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Leukocyte adherence inhibition: tumor specificity of cellular and serum-blocking reactions in human melanoma, breast cancer, and colorectal cancer.
    Halliday WJ; Koppi TA; Khan JM; Davis NC
    J Natl Cancer Inst; 1980 Aug; 65(2):327-35. PubMed ID: 6157045
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-tumor immunity in breast cancer evaluated by a computerized tube leukocyte adherence inhibition (LAI) assay.
    Fink A; Shani A; Feldman B; Wechsler U; Pfeffermann R; Eliraz A; Offer S; Harpaz N; Bentwich Z
    Eur J Surg Oncol; 1989 Feb; 15(1):17-9. PubMed ID: 2645173
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Leukocyte-adherence inhibition: a specific assay of cell-mediated immunity dependent on lymphokine-mediated collaboration between T lymphocytes.
    Powell AE; Sloss AM; Smith RN
    J Immunol; 1978 Jun; 120(6):1957-66. PubMed ID: 77883
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Humoral leukocyte adherence inhibition (H-LAI) before and after surgery in human breast cancer.
    Horváth M; Tóth L; Tóth J; Fekete B
    Neoplasma; 1985; 32(5):623-7. PubMed ID: 3906415
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of the microplate leukocyte adherence inhibition test and its reproducibility, sensitivity, and relationship to other tests of cellular immunity.
    Holt PG; Fimmel PJ; Finlay-Jones LM; Flower RL
    Cancer Res; 1979 Feb; 39(2 Pt 2):564-9. PubMed ID: 367583
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.